Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (71-80 of 236) with videos related to

Pageof 24
Sort By:
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|February 19, 2014
[Expression and function of killer immunologublin receptor and CD57 of natural killer cells]Xiang-yu Zhao, Xiao-su Zhao, Ya-zhe Wang, et al.
Chinese Medical Journal|September 12, 2018
Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34Le-Qing Cao, Lan-Ping Xu, Xiao-Hui Zhang, et al.
The Journal of Infection|June 18, 2016
Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivationJing Liu, Ying-Jun Chang, Chen-Hua Yan, et al.
European Journal of Immunology|May 9, 2015
Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantationXiang-Yu Zhao, Ying-Jun Chang, Xiao-Su Zhao, et al.
Journal for Immunotherapy of Cancer|November 22, 2024
Sintilimab plus decitabine for higher-risk treatment-naïve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trialJing Wang, Siqi Li, Hao Jiang, et al.
Plos One|March 19, 2013
Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantationMeng Lv, Hai-ge Ye, Xiao-su Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 10, 2013
[Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation]Xiang-yu Zhao, Xiao-su Zhao, Ya-zhe Wang, et al.
Zhonghua Nei Ke Za Zhi|December 4, 2009
[Factors influencing engraftment in hematological patients after human leukocyte antigen matched sibling allogeneic blood and marrow transplantation]Ying-Jun Chang, Dai-Hong Liu, Lan-Ping Xu, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Clinical Effects of RUNX1 Mutations on the Outcomes of Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem-Cell TransplantationWei-Jie Ran, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell TransplantationYu-Tong Wang, Yuan Kong, Yang Song, et al.
Pageof 24

Showing results (71-80 of 236) with videos related to

Sort By:
Pageof 24
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|February 19, 2014
[Expression and function of killer immunologublin receptor and CD57 of natural killer cells]Xiang-yu Zhao, Xiao-su Zhao, Ya-zhe Wang, et al.
Chinese Medical Journal|September 12, 2018
Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34Le-Qing Cao, Lan-Ping Xu, Xiao-Hui Zhang, et al.
The Journal of Infection|June 18, 2016
Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivationJing Liu, Ying-Jun Chang, Chen-Hua Yan, et al.
European Journal of Immunology|May 9, 2015
Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantationXiang-Yu Zhao, Ying-Jun Chang, Xiao-Su Zhao, et al.
Journal for Immunotherapy of Cancer|November 22, 2024
Sintilimab plus decitabine for higher-risk treatment-naïve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trialJing Wang, Siqi Li, Hao Jiang, et al.
Plos One|March 19, 2013
Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantationMeng Lv, Hai-ge Ye, Xiao-su Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 10, 2013
[Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation]Xiang-yu Zhao, Xiao-su Zhao, Ya-zhe Wang, et al.
Zhonghua Nei Ke Za Zhi|December 4, 2009
[Factors influencing engraftment in hematological patients after human leukocyte antigen matched sibling allogeneic blood and marrow transplantation]Ying-Jun Chang, Dai-Hong Liu, Lan-Ping Xu, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Clinical Effects of RUNX1 Mutations on the Outcomes of Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem-Cell TransplantationWei-Jie Ran, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell TransplantationYu-Tong Wang, Yuan Kong, Yang Song, et al.
Pageof 24